Pharmacokinetics in children
No information available on pharmacokinetic parameters in children and neoantes
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Hypotension during anaesthesia; cyanotic spells in Tetralogy of Fallot |
- Intravenous
-
1 month
up to
1 year
-
1 year
up to
18 years
-
Premature and
Term neonate
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Adrenergic and dopaminergic agents |
|
|
|
C01CA24
|
|
|
|
C01CA07
|
|
|
|
C01CA04
|
|
|
|
C01CA26
|
|
|
|
C01CA02
|
|
|
|
C01CA17
|
|
|
|
C01CA24
|
|
|
|
C01CA03
|
| Phosphodiesterase inhibitors |
|
|
|
C01CE02
|
| Other cardiac stimulants |
|
|
|
C01CX08
|
References
-
Strong MJ, et al, Arterial gas tensions under anaesthesia in tetralogy of Fallot, Br J Anaesth, 1967, Jun;39(6), 472-9
-
Nudel DB, et al, Effects of acutely increasing systemic vascular resistance on oxygen tension in tetralogy of Fallot., Pediatrics., 1976, Aug;58(2), 248-51.
-
Tanaka K, et al, Phenylephrine increases pulmonary blood flow in children with tetralogy of Fallot. , 2003 , Nov;50(9):, 926-9.
-
Greeley WJ, et al, Intraoperative hypoxemic spells in tetralogy of Fallot. An echocardiographic analysis of diagnosis and treatment., Anesth Analg, 1989, Jun;68(6), 815-9
-
Shaddy RE, et al, Continuous intravenous phenylephrine infusion for treatment of hypoxemic spells in tetralogy of Fallot., J Pediatr., 1989, Mar;114(3), 468-70
-
Oshita S, et al, Correlation between arterial blood pressure and oxygenation in tetralogy of Fallot, J Cardiothorac Anesth., 1989, Oct;3(5), 597-600
-
von Ungern-Sternberg BS, et al, Changes in lung volume during spells in children with Tetralogy of Fallot under general anesthesia., Pediatr Crit Care Med., 2011, Jan;12(1), e40-2.
-
Working group Neonatal pharmacology, Expert opnion on the use of phenylephrine - 05-03-2024
-
E.Koomen - Pediatric Intensivist/pediatric anesthesiologist WKZ/UMCU, Expert opinion on the use of fenylefrine in children, infants and neonates, Personal communication, Feb 2023
-
Tanaka K, et al, Phenylephrine increases pulmonary blood flow in children with tetralogy of Fallot., 2003, Nov;50(9):, 926-9.
Therapeutic Drug Monitoring
Overdose